- Nano Express
- Open Access
Facile Synthesis of Amine-Functionalized Eu3+-Doped La(OH)3 Nanophosphors for Bioimaging
© Sun et al. 2010
Received: 22 July 2010
Accepted: 16 August 2010
Published: 2 September 2010
Here, we report a straightforward synthesis process to produce colloidal Eu3+-activated nanophosphors (NPs) for use as bioimaging probes. In this procedure, poly(ethylene glycol) serves as a high-boiling point solvent allowing for nanoscale particle formation as well as a convenient medium for solvent exchange and subsequent surface modification. The La(OH)3:Eu3+ NPs produced by this process were ~3.5 nm in diameter as determined by transmission electron microscopy. The NP surface was coated with aminopropyltriethoxysilane to provide chemical functionality for attachment of biological ligands, improve chemical stability and prevent surface quenching of luminescent centers. Photoluminescence spectroscopy of the NPs displayed emission peaks at 597 and 615 nm (λex = 280 nm). The red emission, due to 5D0 → 7F1 and 5D0 → 7F2 transitions, was linear with concentration as observed by imaging with a conventional bioimaging system. To demonstrate the feasibility of these NPs to serve as optical probes in biological applications, an in vitro experiment was performed with HeLa cells. NP emission was observed in the cells by fluorescence microscopy. In addition, the NPs displayed no cytotoxicity over the course of a 48-h MTT cell viability assay. These results suggest that La(OH)3:Eu3+ NPs possess the potential to serve as a luminescent bioimaging probe.
Lanthanide-doped phosphors have been investigated and employed in a broad range of technological applications such as solar energy converters, fluorescent lighting and high-performance displays [1, 2]. Recently, nanophosphors (NPs) have received significant attention for use in biological sensing [3–5] and imaging applications [6, 7] due to their unique physical and optical properties. As fluorescent probes, similar to semiconductor quantum dots (QDs), these luminescent NPs offer several advantages over conventional organic fluorophores, including high photochemical stability, large Stokes shift and tunable fluorescence emission . In addition, these rare-earth-based nanoparticles exhibit several distinct and useful characteristics for monitoring molecular and biological interactions [8, 9]. Newly developed NPs exhibit long fluorescence lifetimes, no photoblinking and lower cytotoxicity, which make them attractive alternatives to QDs.
The unique photophysical properties of trivalent lanthanide (Ln3+) ions, which act as luminescence activators in these NPs, result from electronic transitions within the 4f shell. Electrons in these 4f orbitals are shielded from interaction with the chemical environment by the 5s and 5p shells, which are lower in energy, but spacially located outside of the 4f orbitals . This unique electronic configuration gives rise to emission spectra that are characterized by sharp peaks, whose spectral positions are independent of their matrix. However, host materials play a critical role influencing the fine structure and emission intensities by absorbing excitation light and transferring energy to the Ln3+ ions. In addition, this matrix can reduce non-radiative relaxation, such as the O–H vibration of water, which results in luminescence quenching [11, 12]. Lanthanide chelates that bind Ln3+ ions and incorporate organic chromophores, which serve as antenna or sensitizers, have been developed as bioprobes for time-resolved luminescent (TRL) immunoassays and Forster resonant energy transfer (FRET) experiments [13–15]. Although versatile, these organic complexes are subject to photochemical degradation, which remains a major challenge in the development of these biological probes.
In response to a growing demand for more sensitive and robust fluorescence bioimaging agents, inorganic Ln3+-doped NPs composed of rare-earth oxides, oxysulfides, phosphates and fluorides are currently being actively investigated [8, 9]. In these NP platforms, the host matrices tightly bind and sensitize a variety of Ln3+ ions allowing for a wide range of emission colors through selection of dopants. One of the most widely used phosphor activators is trivalent europium (Eu3+) due to its well-characterized emission spectrum resulting from 5DJ(J = 0,1,2) → 7FJ(J = 0,1,2,3) transitions. The use of stable Eu2O3 is limited by high cost and poor luminescence due to strong concentration quenching . In order to improve Eu3+ emission, various rare-earth host NPs have been synthesized by modification of conventional phosphor fabrication processes, such as solid-state and pyrolysis reactions [17, 18]. Although efficient in producing highly luminescent NPs, these synthesis methods typically require specialized equipment and can suffer from particle aggregation limiting their use under physiological conditions. Recent efforts to produce NPs for biological applications have focused on colloidal synthesis methods capable of producing dispersed water-soluble NPs. In addition, surface modification of NPs to improve biocompatibility and allow for conjugation of biological ligands continues to be actively investigated [19–21].
In this study, we present a facile synthesis process to produce ultrafine Eu3+-doped NPs for use as luminescent bioimaging probes. Here, lanthanum hydroxide is utilized as a rare-earth matrix material due to its lack of inherent luminescence  and straightforward conversion to oxides or oxysulfides through dehydration or sulfuration . This wet chemical strategy employs a low-molecular weight poly(ethylene glycol) (PEG) as a high-boiling point solvent allowing for monodispersed NP formation and in situ polymer coating. The physically adsorbed amphililic PEG serves as a temporary barrier to particle aggregation and allows for convenient solvent exchange for subsequent surface modification in either aqueous or organic solutions. Here, we demonstrate surface coating with aminopropyltriethoxysilane (APTES) to improve chemical stability and provide amine functional groups for conjugation of biomolecules. As-synthesized and APTES-coated NPs were characterized to determine their physiochemical and photoluminescence properties. Functionalized NPs were also evaluated as luminescent probes in a conventional biological imaging system and in vitro fluorescence microscopy. In addition, an initial assessment of the biocompatibility of these NPs was performed using a MTT cell viability assay.
Lanthanum nitrate hexahydrate (La(NO3)3·6H2O), poly(ethylene glycol) (PEG, MW 570-630), titianum (IV) isopropoxide Ti(OPr)4 (3-aminopropyl)trimethoxysilane (APTES), dimethyl sulfoxide (DMSO) and MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) were purchased from Sigma–Aldrich (St. Louis, MO). Europium oxide (Eu2O3), nitric acid (HNO3) and toluene were purchased from Acros Organics (Morris Plains, NJ). Sodium hydroxide (NaOH) and 200 proof ethanol (EtOH) were purchased from Fisher Chemical (Fairlawn, NJ). All reagents were used without further purification. Deionized (D.I.) water was obtained from an ultrapure water purification system (Barnstead Nanopure, Thermo Scientific, Dubuque, IA). Dulbecco's modified Eagle's medium (DMEM), fetal bovine serum (FBS), phosphate-buffered saline (PBS), penicillin/streptomycin, TrypLE and Trypan blue were purchased from Gibco (Invitrogen, Carlsbad, CA).
Nanophosphor Synthesis and Surface Modification
Eu3+-doped NPs were obtained through a high-temperature precipitation in low-molecular weight PEG. Initially, 39 mg Eu2O3 was dissolved in 0.2 ml 35% HNO3 under magnetic stirring. Then, 1.9 g La(NO3)3·6H2O was dissolved in 0.8 mL of D.I. water and combined with the dissolved Eu2O3 and 40 mL of PEG. A volume of 1.0 mL of 6 M NaOH was then added dropwise under vigorous stirring, and the mixture was heated to 140°C for 1 h. The reaction vessel was then sealed and heated for 3 h at 140°C. The resulting colloidal solution was cooled to room temperature and diluted 1:10 in EtOH. To isolate the NPs, 50-mL aliquots of the NPs mixture were centrifuged at ~2,500 RPM for 5 min. The supernatant was decanted to remove excess PEG and reaction byproducts. NPs were washed twice by redispersing them in 50 mL of EtOH followed again by centrifugation and decanting the supernatant. The particles were then resuspended in 50 mL of anhydrous toluene. Surface modification was performed with the addition of 0.5 mL APTES and 50 μL Ti(OPr)4, as a catalyst, for 12 h at 40°C in an ultrasonic bath (Branson Ultrasonic Corp., Danbury, CA). The coated NPs were centrifuged, and excess APTES and Ti(OPr)4 were decanted. The resulting NPs were purified by washing three times with ethanol and D.I. water, respectively.
Physiochemical Characterization of Nanophosphors
Transmission electron microscopy (TEM) samples were prepared by dipping 400-mesh copper grids (Veco, Ted Pella, Redding, CA) in a diluted suspension of NPs in EtOH. The grids were then dried and imaged on a JEOL TEM1230 (Tokyo, Japan) operating at 80 kV. Digital TEM images were acquired with a Gatan 967 (Pleasanton, CA) slow scan, cooled CCD camera. Particle size distribution was calculated using NIH ImageJ with the particle size analyzer (PSA) macro. Powder X-ray diffraction (XRD) patterns were acquired from dried samples with a PANalytical X'Pert (Almelo, Netherlands) diffractometer using Cu-Kα radiation (λ = 1.541Å) at 40 kV and 20 mA. X-ray photoelectron spectroscopy (XPS) experiments were carried out using a Surface Science Instrument S-probe spectrophotometer (Newburyport, MA) with a monochromatized Al X-ray source and 5 eV flood gun for charge neutralization. X-ray spot size for the acquisition was approximately 800 μm. Pressure in the analytical chamber during spectral acquisition was less than 5 × 10-9 Torr.
Photoluminescence Characterization of Nanophosphors
Photoluminescence characterization was performed on a FluoroMax-4 spectrofluorometer (Horiba Scientific, Edison, NJ). Images of NP emission intensity as a function of concentration were obtained on a Xenogen Illumina system (Caliper Life Sciences, Hopkinton, MA). For imaging, optical phantoms were prepared over a range of concentration in 1% agarose. Fluorescence emission was normalized to photons per second per centimeter squared per steradian (p/s/cm2/sr).
In Vitro Imaging Assay
Human cervical adenocarcinoma HeLa cells were cultured in DMEM supplemented with 10% FBS and 1% penicillin/streptomycin at 37°C in a humidified atmosphere with 5% CO2. Cells were grown on 75-cm2 cell-culture flasks with 10 mL of media that was changed every second day. To assess the optical detection of the NPs in a biological sample, cells were incubated with the NPs at a concentration of 100 μg NP/ml for 4 h at 37°C. Cells were then washed twice with PBS and incubated with TrypLE solution (substitute for porcine trypsin) for 5 min at 37°C to detach them from the flask. Cell density was determined through staining with trypan blue and counting cells using a hemocytometer with 0.9-mm3 counting chamber. To evaluate NP fluorescence from bulk cell sample, 106 cells were fixed in methanol at -20°C for 15 min and centrifuged to isolate a pellet for imaging. For fluorescence microscopy, cells preincubated with NPs, as described earlier, were seeded on 24-mm glass cover slips and incubated for 18 h to allow them to attach. Cells were then washed with PBS three times and fixed in methanol at -20°C for 15 min. The cover slips were then mounted on slides using Prolong Gold antifade solution with DAPI (4',6-diamidino-2-phenylindole) (Invitrogen, Carlsbad, CA) for cell nuclei staining and fluorescence preservation. The slides were examined by fluorescence microscopy using a Leica fluorescence microscope (Wetzlar, Germany) equipped with excitation/emission filter cubes for DAPI and FITC (fluorescein isothiocyanate). Here, an FITC 515-nm-long-pass emission filter was used to acquire all NP emission in the green and red spectral region. By convention, signal collected by the DAPI and FITC filter cubes were colored blue and green, respectively.
Cytotoxicity (MTT) Assay
Human breast adenocarcinoma MCF7 cells were cultured in DMEM supplemented with 10% FBS and 1% penicillin/streptomycin at 37°C in a humidified atmosphere with 5% CO2. Cells were then cleaved with TrypLE and counted using a hemocytometer, as described earlier. The cells were then seeded on 96-well plates (5,000 cells/well) in DMEM w/o phenol red. After 12-h incubation, cells were incubated with APTES-coated NPs at concentrations of 0, 0.1, 1.0, 10 and 100 μg/mL in 200 μL DMEM w/o phenol red. In addition, control (cells only) and blank (no cells) samples were also present on the well plates. The cells were then incubated at 37°C for 12, 24 and 48 h. Four hours before the end of each time point, 20 μL of 12 mM MTT was added to each well. Upon completion of the incubation, all but 25 μL of the medium was removed, and 50 μL of DMSO was added to each well to dissolve the formazan crystals. The samples were then mixed thoroughly with pipetting, and the absorbance read at 540 nm on a microplate reader (Tecan, Mannedorf, Switzerland).
Results and Discussion
Nanophosphor Synthesis and Surface Modification
The structure and composition of the NPs were analyzed by X-ray characterization techniques. Powder XRD was performed on the APTES-coated NPs (Figure 2c). Peaks consistent with crystalline La(OH)3 were observed (JCPDS 36-1481); however, additional peaks were also detected and attributed to the presence of La2O3 and possibly the Eu3+ dopant. Furthermore, the relatively low intensity of the peaks suggests a significant amorphous phase is present and likely due to extensive reconstruction at the surface of these nanoparticles. In comparison with previous reports [28, 29], the use of PEG as a surfactant in this hydrothermal synthesis of La(OH)3 NPs significantly reduces the overall size of the nanostructure with a trade-off of well-defined crystal structure. Previously, polyol synthesis methods employing diethylene glycol to produce Y2O3:Eu3+ and Gd2O3:Eu3+ NPs have been reported . Here, we employ PEG as a more biologically friendly and solvent compatible reaction medium for surface modification. Further processing by annealing the NPs synthesized in PEG and conversion to lanthanum oxide or lanthanum oxysulfide  are potential areas of optimization for this NP platform; however, these processes are beyond the scope of this work.
In Vitro Cell Labeling
In this study, we have developed a facile synthesis process to produce luminescent water-soluble La(OH)3:Eu3+ NPs for biological applications. The NPs obtained from this process are ~ 3.5 nm in size and display optical emission typical for Eu3+-activated probes with 5D0 → 7F1 and 5D0 → 7F2 transitions. Surface functionalization with APTES was confirmed with XPS and shown to enhance luminescence intensity by ~ 44%. In addition, the amine terminal groups of the APTES-coated NPs provide reactive sites for bioconjugation. Combining the ability to attach a variety of biological ligands with selection of Ln3+ dopant–tuned emission, these La(OH)3 NPs may serve as effective multiplex imaging agents for various biological assays . To demonstrate the luminescence of the NPs under biological conditions, an in vitro experiment was performed with HeLa cells. NP emission was observed in the cells by both a conventional bioimaging system and through fluorescence microscopy. In addition, the NPs displayed no apparent cytotoxicity over the course of a 48-h MTT cell viability assay making them suitable optical probes for bioimaging applications.
We gratefully acknowledge our funding sources from the National Science Foundation (Grant No. 0854492) and the NIH (Grant No. R01 CA133474) and NCI ICMIC (Grant No. P50 CA114747). We also acknowledge the laboratory facilities and equipment support provided by the Canary Foundation and Dr. Martin Brown. In addition, we thank Dr. Shoucheng Ning for donating tumor cell lines used in this study.
- Justel T, Nikol H, Ronda C: Angew Chem Int Ed. 1998, 37: 22. 10.1002/(SICI)1521-3773(19981204)37:22<3084::AID-ANIE3084>3.0.CO;2-WView ArticleGoogle Scholar
- Feldmann C, stel TJ, Ronda CR, Schmidt PJ: Adv Func Mater. 2003, 13: 7.Google Scholar
- Casanova D, Bouzigues C, Nguyen TL, Ramodiharilafy RO, Bouzhir-Sima L, Gacoin T, Boilot JP, Tharaux PL, Alexandrou A: Nat Nanotechnol. 2009, 4: 9. 10.1038/nnano.2009.200Google Scholar
- Dosev D, Nichkova M, Liu M, Guo B, Liu GY, Hammock BD, Kennedy IM: J Biomed Opt. 2005, 10: 6. 10.1117/1.2136347View ArticleGoogle Scholar
- Nichkova M, Dosev D, Perron R, Gee SJ, Hammock BD, Kennedy IM: Anal Bioanal Chem. 2006, 384: 3. 10.1007/s00216-005-0246-8Google Scholar
- Wu S, Han G, Milliron DJ, Aloni S, Altoe V, Talapin DV, Cohen BE, Schuck PJ: Proc Natl Acad Sci USA. 2009, 106: 27. 10.1073/pnas.0900125106View ArticleGoogle Scholar
- Chatterjee DK, Rufaihah AJ, Zhang Y: Biomaterials. 2008, 29: 7. 10.1016/j.biomaterials.2007.10.051View ArticleGoogle Scholar
- Shen J, Sun LD, Yan CH: Dalton Trans. 2008., 42:Google Scholar
- Wang F, Tan WB, Zhang Y, Fan X, Wang M: Nanotechnology. 2006, 17: 1. 10.1088/0957-4484/17/1/R01View ArticleGoogle Scholar
- Werts MH: Sci Prog. 2005.,88(2): 10.3184/003685005783238435Google Scholar
- Parker D, Williams JAG: J Chem Soc-Dalton Trans. 1996., 18:Google Scholar
- Bunzli JC: Chem Rev. 2010, 110: 5. 10.1021/cr900362eView ArticleGoogle Scholar
- Bunzli JC, Piguet C: Chem Soc Rev. 2005, 34: 12. 10.1039/b406082mView ArticleGoogle Scholar
- Eliseeva SV, Bunzli JC: Chem Soc Rev. 39: 1.Google Scholar
- Thibon A, Pierre VC: Anal Bioanal Chem. 2009, 394: 1. 10.1007/s00216-009-2683-2View ArticleGoogle Scholar
- Dexter DL, Schulman JH: J Chem Phys. 1954, 22: 6. 10.1063/1.1739858View ArticleGoogle Scholar
- Dosev D, Nichkova M, Dumas RK, Gee SJ, Hammock BD, Liu K, Kennedy IM: Nanotechnology. 2007, 18: 5. 10.1088/0957-4484/18/5/055102View ArticleGoogle Scholar
- Kubrin R, Tricoli A, Camenzind A, Pratsinis SE, Bauhofer W: Nanotechnology. 2010, 21: 22. 10.1088/0957-4484/21/22/225603View ArticleGoogle Scholar
- Sivakumar S, Diamente PR, van Veggel FC: Chemistry. 2006, 12: 22.View ArticleGoogle Scholar
- Diamente PR, Burke RD, van Veggel FC: Langmuir. 2006, 22: 4. 10.1021/la052589rView ArticleGoogle Scholar
- Wang F, Zhang Y, Fan XP, Wang MQ: Nanotechnology. 2006, 17: 5.Google Scholar
- Jiang Y, Wu Y, Xie Y, Qian Y-T: J Am Ceram Soc. 2000, 83: 10.Google Scholar
- Debbage P, Jaschke W: Histochem Cell Biol. 2008, 130: 5. 10.1007/s00418-008-0511-yView ArticleGoogle Scholar
- McNeil SE: J Leukoc Biol. 2005, 78: 3. 10.1189/jlb.0205074Google Scholar
- Sun C, Lee JS, Zhang M: Adv Drug Deliv Rev. 2008, 60: 11. 10.1016/j.addr.2008.03.018View ArticleGoogle Scholar
- Choi HS, Liu W, Misra P, Tanaka E, Zimmer JP, Itty Ipe B, Bawendi MG, Frangioni JV: Nat Biotechnol. 2007, 25: 10.Google Scholar
- Choi HS, Liu W, Liu F, Nasr K, Misra P, Bawendi MG, Frangioni JV: Nat Nanotechnol. 2010, 5: 1. 10.1038/nnano.2009.314Google Scholar
- Mu Q, Chen T, Wang Y: Nanotechnology. 2009, 20: 34.Google Scholar
- Tang B, et al.: Nanotechnology. 2004, 15: 12.Google Scholar
- Bazzi R, Flores MA, Louis C, Lebbou K, Zhang W, Dujardin C, Roux S, Mercier B, Ledoux G, Bernstein E, Perriat P, Tillement O: J Colloid Interface Sci. 2004, 273: 1. 10.1016/j.jcis.2003.10.031View ArticleGoogle Scholar
- Liu Z, Sun X, Xu S, Lian J, Li X, Xiu Z, Li Q, Huo D, Li J-G: J Phys Chem C. 2008, 112: 7.View ArticleGoogle Scholar
- Arkles B: Silane coupling agents: connecting across boundaries V2.0. 2006.Google Scholar
- Hermanson G: Bioconjugate techniques. Academic Press, San Diego; 1996.Google Scholar
- Aslam M, Dent A: Bioconjugation. Macmillan Reference Ltd, London; 1998.Google Scholar
- Park JK, Park SM, Kim CH, Park HD, Choi SY: J Mater Sci Lett. 2001, 20: 24.Google Scholar
- Hosono E, Fujihara S: Chem Commun. 2004., 18:Google Scholar
- Werts MHV, Duin MA, Hofstraat JW, Verhoeven JW: Chem Commun. 1999., 9:Google Scholar
- Mosmann T: J Immunol Methods. 1983, 65: 1–2. 10.1016/0022-1759(83)90303-4View ArticleGoogle Scholar
- Ehlert O, Thomann R, Darbandi M, Nann T: ACS Nano. 2008, 2: 1. 10.1021/nn7002458View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.